Author:
Mohd Ngesom Ahmad Mohiddin,Ahmad Razi Anis,Azizan Nur Syahirah,Wasi Ahmad Nazni,Md Lasim Asmalia,Liang Yanfeng,Greenhalgh David,Min Jasmine Chia Siew,Sahani Mazrura,Hod Rozita,Othman Hidayatulfathi
Abstract
Abstract
Background
Dengue is a significant public health issue that is caused by Aedes spp. mosquitoes. The current vector control methods are unable to effectively reduce Aedes populations and thus fail to decrease dengue transmission. Hence, there is an urgent need for new tools and strategies to reduce dengue transmission in a wide range of settings. In this study, the Mosquito Home System (MHS) and Mosquito Home Aqua (MHAQ) formulations were assessed as commercial autodissemination traps in laboratory and small-scale field trials.
Method
Multiple series of laboratory and small-scale field trials were performed to assess the efficacy of MHS and MHAQ exposed to Ae. aegypti. In the laboratory trials, various parameters such as fecundity, fertility, wing size, oviposition preferences, residual effects, and MHAQ transference to other containers through controlled experiments were tested. For small-scale field trials, the efficacy of the MHS and MHAQ approaches was determined to ascertain whether wild mosquitoes could transfer the MHAQ formulation from MHS stations to ovitraps.
Results
The data revealed that Ae. aegypti was highly susceptible to low concentrations of MHAQ formulations and had a residual effect of up to 3 months, with MHAQ exposure affecting fecundity, fertility, and mosquito wing size. In the oviposition studies, gravid females strongly preferred the hay infusion compared to tap water and MHAQ during egg-laying in the laboratory. Nevertheless, the use of commercial MHAQ by MHS was highly attractive in field settings compared to conventional ovitraps among local Aedes spp. mosquitoes. In addition, MHAQ horizontal transfer activities in the laboratory and small-scale field trials were demonstrated through larval bioassays. These findings demonstrated the potential of MHAQ to be transferred to new containers in each study site.
Conclusion
This study provided proof of principle for the autodissemination of MHAQ. Through further refinement, this technique and device could become an effective oviposition trap and offer an alternative preventive tool for vector control management.
Graphical abstract
Funder
Dengue Tech Challenge 2016 Grant, under the Newton-Ungku Omar Fund Partnership
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference76 articles.
1. Chew CH, Woon YL, Amin F, Adnan TH, Wahab AHA, Ahmad ZE, et al. Rural- urban comparison of dengue seroprevalence in Malaysia. BMC Public Health. 2016;16:824.
2. Yusoff HM. National Dengue Programme in Malaysia, In: Asia-Pacific Dengue Program Managers Meeting, Singapore, 5–9 May 2008. World Health Organization -Western Pacific Region; 2008. p. 83–86.
3. Capeding MR, Tran NH, Hadinegoro SRS, Muhamad Ismail HIHJ, Choypitayasunondh T, Chua MN, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: aphase 3, randomised, observer-masked, placebo-control trials. Lancet. 2014;384(9951):1358–65.
4. Thomas SJ, Yoon IK. A review of dengvaxia® development to deployment. Hum Vacci Immunother. 2019;15(10):2295–314.
5. Silveira LTC, Tura B, Santos M. Systematic review of dengue vaccine. BMC Infect Dis. 2019;19:750.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献